LKB1 is a serine/threonine kinase that is best known for its tumor suppressor functions (Shackelford and Shaw, 2009), but it is increasingly recognized as a key regulator of the nervous system (Kuwako and Okano, 2018). The gene discussed is MARK2; the disease is neoplasm.